[The effects of sulpiride on plasma LH, FSH, and progesterone in women during the reproductive years. Role of hyperprolactinism in ovulation disorders].
D000293:Adolescent; D000328:Adult; D003271:Contraceptive Agents, Female / Q000494:pharmacology*; D003276:Contraceptives, Oral / Q000494:pharmacology; D003338:Corpus Luteum / Q000187:drug effects; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood*; D006801:Humans; D007273:Injections, Intramuscular; D007986:Luteinizing Hormone / Q000097:blood*; D010053:Ovary / Q000187:drug effects; D010060:Ovulation / Q000187:drug effects*; D011247:Pregnancy; D011374:Progesterone / Q000097:blood*; D011388:Prolactin / Q000097:blood; D013469:Sulpiride / Q000008:administration & dosage / Q000494:pharmacology*
D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D011374:Progesterone; D013469:Sulpiride; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone
Evolution sous sulpiride de LH, FSH, et de la progestérone plasmatiques chez la femme en période d'activité génitale. Responsabilité de l'hyperprolactinisme dans les troubles de l'ovulation?